Fund Holdings — Velan Capital Investment Management LP

Total Portfolio Value:
$104.61M
Total Bought:
$18.82M
Total Sold:
$40.40M
Net Transaction:
-$21.58M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Praxis Precision Medicines, Inc.(PRAX)88,78176,600-12,181$29.72M$22.31M21.33%-$7.41M
Immix Biopharma, Inc.(IMMX)1,085,0001,085,0000$11.19M$11.29M10.79%+$103.1K
Protara Therapeutics, Inc.(TARA)2,844,6522,844,6520$10.87M$8.68M8.29%-$2.19M
Sutro Biopharma, Inc.(STRO)512,160510,038-2,122$17.00M$8.22M7.85%-$8.79M
ABIVAX Société AnonymeADS(ABVX)65,63065,6300$8.75M$6.50M6.21%-$2.25M
MapLight Therapeutics, Inc.(MPLT)492,893624,703+131,810$17.67M$6.37M6.09%-$11.30M
Anteris Technologies Global Corp.(AVR)700,000700,0000$6.89M$5.44M5.20%-$1.46M
Edesa Biotech, Inc.(EDSA)827,5001,282,045+454,545$6.73M$5.40M5.16%-$1.33M
Avalo Therapeutics, Inc.(AVTX)324,452324,4520$6.00M$4.97M4.75%-$1.02M
Xencor, Inc.(XNCR)255,000175,000-80,000$4.11M$4.37M4.17%+$260.8K
Evommune, Inc.(EVMN)451,255456,255+5,000$6.00M$3.77M3.60%-$2.23M
Eupraxia Pharmaceuticals Inc.(EPRX)352,000352,0000$2.33M$3.20M3.06%+$876.5K
Heron Therapeutics, Inc.(HRTX)8,753,2908,753,2900$3.74M$2.74M2.62%-$991.7K
Edgewise Therapeutics, Inc.(EWTX)034,250+34,250$0$1.39M1.33%+$1.39M
Rein Therapeutics Inc.(RNTX)1,700,0001,700,0000$1.77M$1.37M1.31%-$401.2K
Nasus Pharma Ltd.(NSRX)359,390359,3900$1.26M$1.33M1.27%+$68.3K
Q32 Bio Inc.(QTTB)0120,000+120,000$0$992.4K0.95%+$992.4K
InspireMD, Inc.(NSPR)148,138924,680+776,542$103.7K$617.5K0.59%+$513.8K
Protagonist Therapeutics Inc3,7003,7000$453.5K$521.3K0.50%+$67.7K
Aardvark Therapeutics Inc085,868+85,868$0$452.5K0.43%+$452.5K
Nurix Therapeutics, Inc.(NRIX)16,00016,0000$388.2K$379.4K0.36%-$8.8K
CytomX Therapeutics, Inc.(CTMX)120,000120,0000$450.0K$326.4K0.31%-$123.6K
Ovid Therapeutics Inc.(OVID)130,000130,0000$349.7K$323.7K0.31%-$26.0K
Mineralys Therapeutics, Inc.(MLYS)11,00011,0000$296.8K$276.4K0.26%-$20.4K
Replimune Group, Inc.(REPL)20,00020,0000$221.4K$264.8K0.25%+$43.4K
Precision BioSciences, Inc.(DTIL)40,00040,0000$314.4K$250.4K0.24%-$64.0K
Zai Lab LimitedADR(ZLAB)09,000+9,000$0$237.1K0.23%+$237.1K
C4 Therapeutics, Inc.(CCCC)570,00070,000-500,000$2.66M$233.1K0.22%-$2.43M
MacroGenics, Inc.(MGNX)60,00060,0000$277.2K$231.6K0.22%-$45.6K
Immunome, Inc.(IMNM)10,00010,0000$211.9K$215.1K0.21%+$3.2K
An2 Therapeutics Inc40,00040,0000$193.6K$212.8K0.20%+$19.2K
Viridian Therapeutics, Inc.(VRDN)10,00010,0000$183.7K$205.9K0.20%+$22.2K
Corbus Pharmaceuticals Holdings, Inc.(CRBP)26,00030,000+4,000$243.9K$204.6K0.20%-$39.3K
Enanta Pharmaceuticals, Inc.(ENTA)015,000+15,000$0$197.7K0.19%+$197.7K
Scynexis Inc40,00040,0000$162.8K$197.6K0.19%+$34.8K
Artiva Biotherapeutics, Inc.(ARTV)25,00025,0000$242.5K$178.0K0.17%-$64.5K
Rocket Pharmaceuticals, Inc.(RCKT)60,00060,0000$205.2K$157.8K0.15%-$47.4K
Lyell Immunopharma, Inc.(LYEL)105,00015,000-90,000$1.48M$146.8K0.14%-$1.33M
Jade Biosciences Inc010,000+10,000$0$140.5K0.13%+$140.5K
Neumora Therapeutics, Inc.(NMRA)230,000230,0000$391.0K$137.1K0.13%-$253.9K
Larimar Therapeutics, Inc.(LRMR)33,00033,0000$100.7K$105.4K0.10%+$4.8K
Kalaris Therapeutics, Inc.(KLRS)25,00025,0000$101.8K$72.3K0.07%-$29.5K
Adma Biologics Inc250,0000-250,000$2.09M$0—-$2.09M
Context Therapeutics Inc.(CNTX)59,7000-59,700$33.1K$0—-$33.1K
Gossamer Bio, Inc.(GOSS)70,0000-70,000$11.5K$0—-$11.5K
Jasper Therapeutics, Inc.(JSPR)2,668,3950-2,668,395$1.12M$0—-$1.12M
Karyopharm Therapeutics Inc.(KPTI)20,0000-20,000$195.4K$0—-$195.4K
Profound Medical Corp.(PROF)170,2780-170,278$1.13M$0—-$1.13M
Proqr Thrapeutics N VSHS EURO
SHS EURO
45,0000-45,000$83.7K$0—-$83.7K
Quoin Pharmaceuticals, Ltd.ADS(QNRX)32,3720-32,372$156.7K$0—-$156.7K
Rezolute, Inc.(RZLT)750,0000-750,000$3.90M$0—-$3.90M
Syndax Pharmaceuticals, Inc.(SNDX)10,0000-10,000$218.6K$0—-$218.6K
Tectonic Therapeutic, Inc.(TECX)6,0000-6,000$206.3K$0—-$206.3K
Tenax Therapeutics, Inc.(TENX)549,9850-549,985$8.00M$0—-$8.00M
Verrica Pharmaceuticals Inc.(VRCA)471,5590-471,559$2.89M$0—-$2.89M
Xilio Therapeutics, Inc.(XLO)14,2850-14,285$136.8K$0—-$136.8K
Page 1 of 1
Velan Capital Investment Management LP — 13F Holdings — Q3 2026 | TickerTrail